These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 1982914)
1. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
3. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. Ramirez B; Richter JE Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981 [TBL] [Abstract][Full Text] [Related]
5. Prokinetic therapy for gastroesophageal reflux disease. Robinson M Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432 [TBL] [Abstract][Full Text] [Related]
6. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis. Brown CK; Khanderia U Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745 [TBL] [Abstract][Full Text] [Related]
7. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
8. [Prokinetic drugs]. Hellström P Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341 [TBL] [Abstract][Full Text] [Related]
9. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
10. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
11. [Drug therapy of gastrointestinal motility disorders]. Jia B Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932 [No Abstract] [Full Text] [Related]
12. Drug therapy of reflux oesophagitis: an update. Tytgat GN Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792 [TBL] [Abstract][Full Text] [Related]
13. Prokinetic agents in postgastrectomy patients. Patterson DJ Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253 [TBL] [Abstract][Full Text] [Related]
14. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related]
16. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride. Megens AA; Awouters FH; Niemegeers CJ Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352 [TBL] [Abstract][Full Text] [Related]
17. Prokinetic therapy in gastroesophageal reflux disease. Champion MC Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180 [TBL] [Abstract][Full Text] [Related]
18. Domperidone: a peripherally acting dopamine2-receptor antagonist. Barone JA Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535 [TBL] [Abstract][Full Text] [Related]